Skip to main content
. 2017 Oct;17(5):412–418. doi: 10.7861/clinmedicine.17-5-412

Table 2.

Patient GSRS symptom occurrence change from pre- to post-treatment assessment

Symptom Frequency of occurrence n Initial assessment, n (%) Follow-up, n (%) McNemar p-value
Never/occasional Frequent/CMCL Never/occasional Frequent/CMCL
Urgency to open bowels 107 55 (51) 52 (49) 72 (67) 35 (33) 0.005
Abdominal bloating 99 69 (70) 30 (30) 77 (78) 22 (22) 0.100
Faecal incontinence 96 70 (73) 26 (27) 81 (84) 15 (16) 0.013
Flatulence 106 60 (57) 46 (43) 76 (72) 30 (28) 0.005
Abdominal pain 107 60 (56) 47 (44) 77 (72) 30 (28) 0.001
Steatorrhoea 91 73 (80) 18 (20) 83 (91) 8 (9) 0.031
Nocturnal defecation 104 74 (71) 30 (29) 87 (84) 17 (16) 0.001
Tenesmus 104 65 (63) 39 (37) 70 (67) 34 (33) 0.359
Belching 107 84 (79) 23 (21) 96 (90) 11 (10) 0.008
Nausea 106 84 (79) 22 (21) 94 (89) 12 (11) 0.021
Vomiting 107 97 (91) 10 (9) 103 (96) 4 (4) 0.031
Heartburn 107 89 (83) 18 (17) 96 (90) 11 (10) 0.144
Borborygmi 106 65 (61) 41 (39) 81 (76) 25 (24) 0.004

CMCL = causes major changes in life; GSRS = gastrointestinal symptom rating scale